Conference abstract · 13 Oct 2016
Conference abstractPublished 13 Oct 2016
Penicillin revisited
Drexel University College of Medicine, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Previously, we have shown that penicillin treated not only acute bacterial infections many of which were debilitating or fatal but also various chronic disorders not even considered to be infectious in nature. These were psoriasis, arthritis and Alzheimer’s disease. To these we now add Lyme disease and atherosclerosis which would benefit from this agent. Underlying many of these chronic diseases we have shown the presence of microbes which form biofilms which cause the activation of the innate immune system which activates the MyD88 pathway which results in TNF alpha which attempts to destroy the microbes. The TNF alpha cannot penetrate the biofilm encasing the organisms thus destroys the surrounding tissue instead. If the adaptive immune system is activated, as in some cases of psoriasis and Alzheimer’s disease (especially after stroke), the tissue destruction is much more rapidly and intensively damaging. Many more biofilm dispersing agents (such as piperidines and pyrroles) will be presented as will biofilm forming states and agents (such as hyperosmolality and low dose antibiotics). Special mention of Beta-Methylamine-L-Alanine (BMAA) and L-serine will be made. The addition of these dispersing agents to penicillin in many patients promises to be most beneficial.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 14 Sep 2015
Penicillin: The new/old wonder drug
Conference abstract · 14 Sep 2015
Glycopeptides revisited
Conference abstract · 20 Jul 2017
Revisiting antidotes in the treatment of oraganophosphorus poisoning
Opinion · 13 Jun 2023
Penicillin Antibiotics: From Discovery to Future Perspectives
More from this journal
The newest in Journal of Drug Metabolism & Toxicology.
Short communication · 30 Dec 2025
Liver Drug Metabolism Mechanisms Challenges and Future Perspectives
Opinion · 30 Dec 2025
Hepatic metabolism forms the foundation of drug disposition in the human body
Opinion · 30 Dec 2025
Biomarkers of Toxicity for Monitoring Adverse Drug Reactions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Drug Metabolism & Toxicology
- SubjectDiabetes & Endocrinology
- SubjectPharmaceutical Sciences
- SubjectToxicology
- BylineArticles whose byline prints “Herbert B Allen”

